A New Macrobicyclic Phosphane Oxide Cryptand
duced pressure. The residue was dissolved in THF, and after ad-
dition of NaOH (4%, 10 mL), the solution was stirred for an ad-
ditional 30 min at room temperature. The solvent was evaporated,
and the crude product was dissolved in CH2Cl2 and washed with
water. After separation of the phases, extraction of the aqueous
phase with CH2Cl2, treatment of the combined organic layers with
saturated solutions of NaHCO3, NH4Cl and NaCl, and drying with
MgSO4, the solvent was evaporated. After column chromatography
on silica gel with EtOAc/CH2Cl2 = 1:4, compound 4 was obtained
as a yellow solid (78.3 mg, 0.058 mmol, 45%); m.p. 126 °C. 1H
NMR (500 MHz, [D6]DMSO, 25 °C): δ = 1.54 (s, 18 H, 16-H), 1.56
147.76 (C-6 or C-9), 156.28 (C-14), 156.50 (C-1) ppm. 31P NMR
(122 MHz, CDCl3, 25 °C): δ = 28.48 (s) ppm. ESI-MS (100 V):
m/z (%) = 1467.8 (100) [M + H]+. IR (ATR): ν = 2962, 2927, 2866,
˜
1605, 1507, 1459, 1401, 1360, 1297, 1221, 1180, 1113, 1014, 827,
677 cm–1.
Phosphane–Borane Complex 7: The following reaction procedure is
based on a method described by Odinets et al. for the reduction of
phosphane oxides with trichlorosilane and subsequent trapping of
the products as phosphane–borane complexes.[12] In
a flask
(25 mL) under argon, macrobicycle 6 (95.4 mg, 0.065 mmol) was
dissolved in dry benzene. HSiCl3 (0.07 mL, 88.9 mg, 0.650 mmol)
was added. The reaction mixture was stirred for 24 h at room tem-
perature, and the progress of the reaction was followed by thin-
layer chromatography with CH2Cl2 (phosphane: Rf ≈ 1, phosphane
oxide: Rf ≈ 0.4). Subsequently, the reaction was quenched with a
1 solution of BH3–THF (0.97 mL, 83.8 mg, 0.975 mmol) in THF
and stirred for 15 min at room temperature. After addition of water
and extraction with EtOAc, the combined organic layers were
washed with a saturated NaCl solution and dried with MgSO4.
After solvent removal and column chromatography on silica gel
with pentane/diethyl ether = 3:1, the phospane–borane complex 7
was obtained as a yellow solid (19.8 mg, 0.014 mmol, 21%);
m.p. 184 °C. 1H NMR (500 MHz, CDCl3, 25 °C): δ = 1.64 (s, 36
H, 15/16-H), 5.01 (s, 6 H, 17-H), 5.02 (s, 6 H, 20-H), 6.81 (d, 3JHH
3
(s, 18 H, 15-H), 5.12 (s, 6 H, 17-H), 6.64 (d, JHH = 8.6 Hz, 6 H,
3
3
2-H), 6.89 (d, JHH = 8.7 Hz, 6 H, 13-H), 6.99 (d, JHH = 8.6 Hz,
3
6 H, 3-H), 7.07 (s, 12 H, 7/8-H), 7.11 (d, JHH = 8.7 Hz, 6 H, 12-
H), 7.59 (dd, 4JPH = 1.9, 3JHH = 8.2 Hz, 6 H, 19-H), 7.65 (dd, 3JPH
3
= 11.4, JHH = 8.2 Hz, 6 H, 20-H), 9.18 (s, 3 H, OH), 11.68 (s,
hydrogen bonding, ≈ 0.12 H, weakens after dehydration in the vac-
uum oven) ppm. 13C NMR (126 MHz, [D6]DMSO, 25 °C): δ =
30.55 (C-15), 30.64 (C-16), 41.25 (C-5), 41.40 (C-10), 68.58 (C-17),
114.17 (C-13), 114.68 (C-2), 125.93 (C-7 or C-8), 125.97 (C-7 or C-
3
8), 127.38 (C-3), 127.57 (C-12), 127.60 (d, JPC = 12.1 Hz, C-19,
signal partially overlapped by C-12), 131.75 (d, 2JPC = 10.0 Hz, C-
20), 132.05 (d, 1JPC = 103.4 Hz, C-21), 140.46 (C-4), 141.62 (C-18),
142.78 (C-11), 147.33 (C-6), 147.80 (C-9), 155.06 (C-1), 156.03 (C-
14) ppm. 31P NMR (203 MHz, [D6]DMSO, 25 °C): δ = 25.00 (s)
ppm. ESI-MS (–75 V): m/z (%) = 1351.2 (100) [M – H]– found,
3
= 8.8 Hz, 6 H, 13-H), 6.83 (d, JHH = 8.9 Hz, 6 H, 2-H), 7.10–7.11
4
(m, 24 H, 3/7/8/12-H), 7.42 (s, 3 H, 19-H), 7.45 (dd, JPH = 1.8,
1351.7 [M – H]– calcd. IR (ATR): ν = 3037 (w, br), 2961, 2924,
˜
3
3
3JHH = 8.1 Hz, 6 H, 22-H), 7.55 (dd, JPH = 10.6, JHH = 8.3 Hz,
6 H, 23-H) ppm. 13C NMR (76 MHz, CDCl3, 25 °C): δ = 30.68
(C-15 or C-16), 30.77 (C-15 or C-16), 41.85 (C-5/10), 69.27 (C-20),
2852, 1607, 1508 (st, P-phenyl), 1460, 1402, 1361, 1297, 1225 (st,
P=O), 1178 (st), 1117, 1089, 1015, 828 (st, p-disubst. aromatics),
679 cm–1. C93H93O7P (1353.70): calcd. C 82.51, H 6.92; found C
82.48, H 6.94.
69.72 (C-17), 114.04 (C-2 or C-13), 114.09 (C-2 or C-13), 125.83
3
(C-19), 126.22 (C-7 or C-8), 126.24 (C-7 or C-8), 127.53 (d, JPC
=
1
10.4 Hz, C-22), 127.77 (C-3/12), 128.52 (d, JPC = 58.4 Hz, C-24),
133.40 (d, JPC = 10.0 Hz, C-23), 138.00 (C-18), 140.83 (C-21),
Macrobicyclic Phosphane Oxide (6): In a flask (1 L) under argon,
a suspension of dry K2CO3 (7.96 g, 57.620 mmol) and KI (0.024 g,
0.144 mmol) in dry DMF (650 mL) was provided. After heating to
110 °C, a solution of alcohol 4 (0.65 g, 0.480 mmol) in dry DMF
(50 mL) and simultaneously a solution of 1,3,5-tri(bromomethyl)-
benzene 5[20] (0.171 g, 0.480 mmol) in dry DMF (50 mL) were
added dropwise with two perfusors over about 2 h with equal drop
speeds. The reaction mixture was stirred at 110 °C for 42 h, during
which the solution colour changed from pink to grey. The reaction
was quenched with a saturated NaHCO3 solution, stirred for ad-
ditional 10 min at 110 °C, and then cooled to room temperature.
The solvent was evaporated under reduced pressure, and the resi-
due was dissolved in THF. The organic phase was washed with
saturated solutions of NH4Cl and NaCl, and dried with MgSO4.
After evaporation of the solvent and column chromatography on
silica gel with CH2Cl2/EtOH = 100:5, the product 6 was obtained
as a yellow solid (0.364 g, 0.248 mmol, 52%). Compound 6 could
be recrystallised from CH2Cl2/acetone to form thin plates;
m.p. 170 °C. 1H NMR (300 MHz, CDCl3, 25 °C): δ = 1.58 (s, 36
H, 15/16-H), 4.94 (s, 6 H, 17-H), 4.97 (s, 6 H, 20-H), 6.74* (dd,
3JHH = 8.7, 4JHH = 1.9 Hz, 6 H, 13-H), 6.76* (dd, 3JHH = 8.9, 4JHH
2
143.43 (C-4 or C-11), 143.67 (C-4 or C-11), 147.75 (C-6 or C-9),
147.77 (C-6 or C-9), 156.34 (C-14), 156.53 (C-11) ppm. 31P NMR
(203 MHz, CDCl3, 25 °C): δ = 19.67 (s) ppm. ESI-MS (25 V):
m/z (%) = 1483.6 (88) [M(1·11B/1·13C) + NH4]+, 1482.6 (100)
[M(1·11B/12C) + NH4]+, 1481.6 (29) [M(1·10B/12C)+NH4]+. ESI-MS
(100 V): m/z (%) = 1503.7 (34) [M + K]+, 1489.7 (75) [M – BH3+
K]+, 1487.7 (42) [M + Na]+, 1482.7 (18) [M + NH4]+, 1473.7 (79)
[M – BH3+Na]+, 1465.8 (19) [M + H]+, 1451.8 (100) [M –
BH +H]+. IR (ATR): ν = 2959, 2922, 2852, 1509, 1462, 1378, 1243,
˜
3
1182, 1018, 829, 739 cm–1.
Crystal Data of 2: C21H18Br3OP, Mr = 557.05 gmol–1, colourless
crystal 0.20ϫ0.10ϫ0.07 mm3, monoclinic, space group P21/c
(No. 14), a = 17.0513(5) Å, b = 11.4785(3) Å, c = 10.5829(2) Å, α
= 90°, β = 96.511(1)°, γ = 90°, V = 2057.96(9) Å3, Z = 4, ρcalcd.
=
1.798 gcm–3, µ = 5.966 mm–1, empirical absorption correction from
SORTAV (0.382ՅTՅ0.680), λ = 0.71073 Å, T = 223(2) K, ω and
φ scans, 11364 reflections collected (Ϯ h, Ϯ k, Ϯ l), [sinθ/λ] =
0.60 Å–1, 3635 independent (Rint = 0.075) and 2239 observed reflec-
tions [IՆ2σ(I)], 255 refined parameters, R = 0.071, wR2 = 0.172,
max./min. residual electron density 1.53/–0.90 e·Å–3. The structure
was solved by direct methods and refined by full-matrix least-
squares on F2. Hydrogen atoms were calculated and refined as ri-
ding atoms. Br was disordered and refined with split positions.
3
= 1.9 Hz, 6 H, 2-H), 7.03* (s, 12 H, 7/8-H), 7.04* (dd, JHH = 8.5,
4
4JHH = 1.9 Hz, 12 H, 3/12-H), 7.35 (s, 3 H, 19-H), 7.41 (dd, JPH
3
3
3
= 2.4, JHH = 8.2 Hz, 6 H, 22-H), 7.58 (dd, JPH = 11.7, JHH
=
8.2 Hz, 6 H, 23-H) ppm. * signal partially superposed. 13C NMR
(126 MHz, CDCl3, 25 °C): δ = 30.65 (C-15 or C-16), 30.76 (C-15
or C-16), 41.82 (C-5/10), 69.27 (C-20), 69.67 (C-17), 114.02 (C-2
or C-13), 114.05 (C-2 or C-13), 125.80 (C-19), 126.19 (C-7 or C-
Crystal Data of 6: C102H99O7P, Mr = 1467.78 gmol–1, colourless
3
¯
crystal 0.60ϫ0.25ϫ0.10 mm , triclinic, space group P1 (No. 2),
3
8), 126.22 (C-7 or C-8), 127.19 (d, JPC = 12.2 Hz, C-22), 127.76
a = 15.214(3) Å, b = 19.131(1) Å, c = 19.787(4) Å, α = 117.15(1)°,
1
2
(C-3/12), 131.75 (d, JPC = 104.2 Hz, C-24), 132.34 (d, JPC
=
β = 108.52(2)°, γ = 94.98(1)°, V = 4672.3(13) Å3, Z = 2, ρcalcd.
=
10.1 Hz, C-23), 137.97 (C-18), 141.53 (d, JPC = 2.4 Hz, C-21), 1.043 gcm–3,
µ =
0.080 mm–1, absorption correction from
4
143.38 (C-4 or C-11), 143.64 (C-4 or C-11), 147.73 (C-6 or C-9), SADABS (0.795ՅTՅ0.992), λ = 0.71073 Å, T = 198(2) K, φ
Eur. J. Org. Chem. 2008, 5571–5576
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5575